INTECH Investment Management’s Adaptive Biotechnologies ADPT Stock Holding History

INTECH Investment Management’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$650K	Sell	30,284 -4,645	-13%	-$71.2K	0.01%	1224
2026 Q1	$485K	Sell	34,929 -29,462	-46%	-$469K	﹤0.01%	1345
2025 Q4	$1.05M	Buy	64,391 +6,155	+11%	+$100K	0.01%	1109
2025 Q3	$871K	Sell	58,236 -14,369	-20%	-$175K	0.01%	1251
2025 Q2	$846K	Buy	72,605 +14,990	+26%	+$136K	0.01%	1299
2025 Q1	$428K	Buy	57,615 +11,457	+25%	+$88.1K	﹤0.01%	1694
2024 Q4	$277K	Buy	46,158 +11,865	+35%	+$65.4K	﹤0.01%	1873
2024 Q3	$176K	Buy	+34,293	New	+$149K	﹤0.01%	1761

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

INTECH Investment Management's ADPT Position: Q2 2026 in Review

INTECH Investment Management reduced its Adaptive Biotechnologies (ADPT) stake by 13% in Q2 2026, selling an estimated $71.2K and leaving 30,284 shares worth $650K. The position accounts for 0.01% of the portfolio, ranked #1224.

INTECH Investment Management first reported a position in ADPT in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.05M in Q4 2025. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

INTECH Investment Management held 30,284 shares of Adaptive Biotechnologies worth $650K as of Q2 2026.
INTECH Investment Management sold 4,645 Adaptive Biotechnologies shares in Q2 2026, an estimated $71.2K.
Adaptive Biotechnologies made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1224 holding.
INTECH Investment Management first reported a position in Adaptive Biotechnologies in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Adaptive Biotechnologies position peaked at $1.05M in Q4 2025.
300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.